Enlarged prostate (BPH): symptoms, tests and treatment
An enlarged prostate, often called benign prostate enlargement or BPH, is common after 50 and can make it harder to pee. It is not prostate cancer and NHS guidance says it does not increase prostate cancer risk, but the same urinary symptoms can sometimes come from infection, bladder problems, medicines, diabetes, retention or cancer, so new or bothersome symptoms should be checked.1
Key facts
- The prostate sits below the bladder and surrounds the urethra. If it enlarges, it can narrow the channel and make bladder emptying harder.1
- Typical symptoms include hesitancy, weak flow, stopping and starting, straining, dribbling, urgency, frequency, night-time peeing and feeling that the bladder has not emptied.1
- NICE recommends history, medication review, guided examination, urine dipstick, a frequency-volume chart for bothersome symptoms and discussion of PSA testing when appropriate.2
- Mild symptoms may only need monitoring and lifestyle changes. Moderate or severe symptoms may need medicines, and severe or persistent blockage may need a procedure.
- Urgent help is needed if you cannot pee at all, have blood in urine, pain when peeing, fever with urinary symptoms, or feel very unwell.1
What BPH means
BPH stands for benign prostatic hyperplasia. In UK patient guidance you will often see benign prostate enlargement, or BPE, because symptoms are caused by the prostate being enlarged rather than by the microscope finding alone. The word benign matters: this is not cancer. The problem is mechanical and functional. An enlarging prostate can press on the urethra, while the bladder muscle may become overactive or less efficient over time.
This is why prostate size and symptom severity do not always match. Some men with large prostates pee reasonably well. Others with smaller prostates have severe urgency, weak flow or retention because of the shape of the prostate, bladder neck, bladder muscle or medicines. The aim is not simply to "shrink the prostate". The aim is to reduce bothersome symptoms, protect bladder and kidney function, avoid retention, and preserve quality of life and sexual priorities where possible.
BPH can affect anyone with a prostate. It is most common in men over 50, and NHS guidance says family history may increase risk.1 It is also common for symptoms to build slowly, so people often adapt without noticing how much sleep, travel, exercise or confidence has changed.
Symptoms and red flags
Lower urinary tract symptoms, shortened to LUTS, are usually grouped into three patterns: storage symptoms, voiding symptoms and after-urination symptoms. Storage symptoms are urgency, frequency, needing to pee at night and leakage. Voiding symptoms are difficulty starting, weak stream, stopping and starting, straining and taking a long time to finish. After-urination symptoms include dribbling and the feeling that the bladder has not fully emptied.
| Symptom pattern | Common explanation | Why it matters |
|---|---|---|
| Weak flow, hesitancy, straining | Possible bladder outlet obstruction from enlarged prostate | May respond to alpha blockers, 5-alpha reductase inhibitors or procedures depending on severity |
| Urgency, frequency, leakage | Overactive bladder, irritation, infection, diabetes, caffeine, medicines or BPH-related bladder changes | Treating the prostate alone may not fix storage symptoms |
| Night-time peeing | Evening fluids, alcohol, sleep apnoea, leg swelling, diabetes, diuretics, heart or kidney problems | Nocturia is not always a prostate problem |
| Cannot pee at all | Acute urinary retention | Needs urgent assessment and often catheter treatment |
| Blood, pain, fever or feeling unwell | Infection, stones, cancer, prostatitis or another urgent cause | Needs prompt medical assessment, not watchful waiting |
NHS guidance says to see a GP for difficulty peeing or needing to pee more frequently, and to seek urgent GP or NHS 111 help for blood in urine, pain when peeing, or being unable to pee at all.1 Also seek same-day help if urinary symptoms come with fever, chills, back pain, confusion, vomiting, severe pelvic pain or feeling very unwell.
Do not normalise retention: a bladder that cannot empty can become an emergency. Sudden inability to pee, severe lower abdominal pain or overflow leakage with a painful full bladder needs urgent help.
How it is assessed
A good assessment starts with a timeline. When did symptoms start? Are they slowly progressive or sudden? Which is worse: weak flow, urgency, night-time peeing, leakage or incomplete emptying? How much caffeine, alcohol and evening fluid do you have? Do symptoms change with constipation, cold remedies, antihistamines, antidepressants, diuretics or decongestants?
NICE recommends reviewing medical history and medicines, doing an examination guided by symptoms, examining the abdomen and external genitalia, and offering a digital rectal examination at initial assessment.2 A urine dipstick should be offered to check for blood, glucose, protein, leucocytes and nitrites. Men with bothersome symptoms should be asked to complete a urinary frequency-volume chart, which is usually more revealing than memory alone.2
PSA testing is a discussion, not an automatic answer. NICE says men with LUTS should be offered information, advice and time to decide about PSA testing if symptoms suggest bladder outlet obstruction from benign prostate enlargement, if the prostate feels abnormal on rectal examination, or if they are concerned about prostate cancer.2 NHS PSA guidance also stresses that the test has limitations.3 PSA can rise with BPH, prostatitis, recent ejaculation, cycling, urinary retention and prostate cancer, so the result needs context.
Initial assessment does not always need scans or cystoscopy. NICE says not to routinely offer cystoscopy, upper-tract imaging, flow-rate measurement or post-void residual measurement to men with uncomplicated LUTS at initial assessment.2 Specialist assessment may use flow testing, bladder residual measurement, ultrasound or cystoscopy when symptoms are severe, complicated, painful, associated with blood, or not responding to treatment.
What you can do yourself
Lifestyle changes are not a cure for obstruction, but they can reduce symptom load. NHS guidance suggests cutting down alcohol and caffeine if they make you pee more, reducing fluids before bed or before going out while still drinking enough overall, eating enough fibre to prevent constipation, keeping a healthy weight and double voiding by waiting a few moments after peeing and trying again.1
Do not push or strain hard to pee. Try to relax, give yourself time, and avoid "just in case" toilet trips every few minutes, which can train the bladder into a smaller comfort zone. If urgency and leakage dominate, bladder training or continence support may help. NICE recommends supervised bladder training, advice on fluid intake and lifestyle advice for storage LUTS suggestive of overactive bladder.2
Review medicines with a pharmacist or GP. Decongestants, some antihistamines, some antidepressants, diuretics, anticholinergic medicines, opioids and alcohol can worsen urinary symptoms in some people. Do not stop prescribed treatment abruptly, but bring a full medicine and supplement list to the appointment.
Medicines
NICE recommends drug treatment for bothersome LUTS only when conservative management has not worked or is not appropriate.2 The choice depends on the dominant symptom pattern, prostate size, PSA context, side-effect priorities, blood pressure, falls risk, sexual function and whether symptoms are mainly obstruction or urgency.
| Option | When it is used | Important trade-offs |
|---|---|---|
| Alpha blockers, such as tamsulosin, alfuzosin or doxazosin | NICE says to offer an alpha blocker for moderate to severe LUTS.2 | Can work relatively quickly, but may cause dizziness, low blood pressure or ejaculation changes. |
| 5-alpha reductase inhibitors, such as finasteride or dutasteride | For larger prostates or higher progression risk. NICE uses prostate over 30 g or PSA over 1.4 ng/ml as markers.2 | Can take months, may affect libido, erections or breast tenderness, and finasteride can affect PSA interpretation.8 |
| Combination alpha blocker plus 5-alpha reductase inhibitor | Considered for bothersome moderate to severe LUTS with larger prostate or PSA over 1.4 ng/ml.2 | Can target both tone and prostate growth, but combines side-effect burdens. |
| Anticholinergic or beta-3 agonist | For overactive bladder symptoms such as urgency, frequency or urge leakage.2 | Needs caution if emptying is poor. Some anticholinergics can cause dry mouth, constipation or cognitive side effects. |
| Nocturia-specific treatment | Only when night-time urine production is the real driver and other causes have been excluded.2 | Desmopressin needs sodium monitoring. NICE lists diabetes, sleep apnoea, oedema, kidney, liver and heart problems as possible causes of nocturnal polyuria. |
Follow-up matters. NICE recommends reviewing men taking alpha blockers at 4 to 6 weeks, then every 6 to 12 months, and reviewing men taking 5-alpha reductase inhibitors at 3 to 6 months, then every 6 to 12 months.2 If symptoms do not improve, the answer may be a different diagnosis, poor bladder emptying, storage symptoms, a larger prostate, medicine side effects or the need for specialist assessment.
Procedures and surgery
Procedures are considered when symptoms are severe, complications occur, or medicines and lifestyle changes have not helped enough. NICE says surgery for voiding symptoms should be offered only if symptoms are severe or conservative and drug options have been unsuccessful or are not appropriate, with discussion of alternatives and outcomes.2
Traditional options include TURP, transurethral vaporisation, HoLEP, TUIP for smaller prostates, and open prostatectomy for very large prostates in selected cases.2 The practical questions are: how much tissue needs removing, how durable the procedure is, catheter time, bleeding risk, anaesthetic risk, retreatment risk, and the likely effect on ejaculation, erections and continence.
Newer or less invasive options may be discussed in urology. NICE says UroLift can relieve LUTS, avoid risk to sexual function and improve quality of life, and should be considered as an alternative to TURP and HoLEP for people aged 50 and older with prostate volume between 30 and 80 ml.4 NICE says Rezum, a water-vapour therapy, is supported for moderate to severe LUTS with a moderately enlarged prostate, typically 30 to 80 cm3.5
Aquablation is robotic water-jet tissue removal. NICE's medtech briefing says evidence from five studies, including one randomised controlled trial and 562 people, suggests Aquablation is as effective as TURP for prostate tissue removal, but further direct comparative evidence is needed.6 Prostate artery embolisation blocks blood supply to shrink the prostate; NICE says evidence is adequate when standard governance, consent and audit arrangements are in place, with selection by a urologist and interventional radiologist.7
Evidence point: there is no single best BPH procedure for everyone. Prostate size, median lobe shape, bladder function, bleeding risk, local expertise, sexual priorities and willingness to accept retreatment risk all change the best choice.
The health library can help you compare BPH with recurrent UTIs, kidney stones, sleep apnoea, diabetes and sexual symptoms. Use start here to prepare a short symptom timeline, insights to sanity-check supplement claims, and the stack builder if you are taking prostate supplements, decongestants, antihistamines or bladder medicines.
- Do my symptoms sound like bladder outlet obstruction, overactive bladder, infection, diabetes, medicines, retention or another cause?
- Should I complete a 3-day frequency-volume chart and an IPSS symptom score before deciding treatment?
- Should I have urine dipstick, PSA discussion, kidney function testing or a rectal examination?
- If I start an alpha blocker or 5-alpha reductase inhibitor, when will we review benefit and side effects?
- At what point should I be referred to urology for flow testing, residual urine measurement, cystoscopy or procedure options?
References
- NHS, 2025. Enlarged prostate. link
- NICE, 2015, reviewed 2024. Lower urinary tract symptoms in men: management, CG97 recommendations. link
- NHS, 2024. PSA test. link
- NICE, 2021. UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia, HTG578 recommendations. link
- NICE, 2020. Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia, HTG545 recommendations. link
- NICE, 2023. Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia, MIB315 summary. link
- NICE, 2018. Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia, HTG469 recommendations. link
- NHS, 2023. About finasteride. link
Nine free tools on this site help you act on what you just read: keep a think-out-loud health journal, prepare a GP appointment, check a supplement stack before buying more, or decode blood results.
Symptom Decoder · Health Journal · GP Script Generator · Stack Risk Checker · Lab Result Primer · Health MOT · All tools. Want it all synced and organised in one private map? The Club, £10/month.
This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Medication uses described as “off-label” are not licensed for that purpose in the UK and should only be considered under qualified clinical supervision. Always speak to your GP, pharmacist, or a registered specialist before starting, stopping, or changing any treatment. If you have severe or alarm symptoms - unintentional weight loss, blood in your stool, difficulty swallowing, persistent vomiting, a fever, or severe pain - seek urgent medical care.